WATCH
Anti-imperfection concentrate
Enriched with AHA BHA and 3 essential Ceramides
Blemished and acne-prone skin
40ml

Developed in collaboration with dermatologists, the CeraVe Concentrate Anti-Blemish Treatment removes imperfections in acne-prone skin, hydrating, soothing and restoring the skin barrier.

Formulated with a powerful concentration of AHA-BHA (alpha-hydroxy acids - beta-hydroxy acids, known for their exfoliating properties), it acts deeply and on the surface to fight imperfections at the source and prevent their reappearance.

- AHA: Glycolic Acid + Lactic Acid: remove dead skin cells and blemishes while reducing inflammation.
- BHA: 2% salicylic acid: unclogs and tightens pores, smoothes and improves skin structure.

This complete daily anti-acne treatment, enriched with 3 essential Ceramides, Niacinamide and Hyaluronic Acid, hydrates for 8 hours*, soothes and restores the skin barrier. With the patented MVE® technology inspired by medicine, for a prolonged diffusion of the active ingredients into the skin and an action for 24 hours.
Its fresh gel texture quickly penetrates the skin for a non-greasy and non-sticky effect.
Its high tolerance formula, tested under dermatological control, complies with a rigorous formulation charter to satisfy sensitive skin: fragrance-free, alcohol-free, hypoallergenic, with a physiological pH and non-comedogenic. Facial formula, suitable for daily use by adolescents and adults.

*Instrumental test, measurement of hydration with the corneometer. Clinically proven anti-acne effectiveness.
Significant results after just 3 days of use*: 45% reduction in the size of acne manifestations.

After just 3 days of use**:

- 90% achieved softer skin
- 78%: smoother skin and a refined skin texture
- 72%: reductions in imperfections and acne spots
- 80%: already satisfied with the product

Significant anti-acne efficacy, clinically proven after 4 weeks of use*: on open comedones (blackheads), inflammatory lesions, redness, papules and pustules. The skin is smoother, with a healthier appearance, the pores are tightened.

Clinical study in monotherapy, F&H, 13-45 years, oily skin, acne-prone skin (mild to moderate), 1 application per day on the face in the evening + 1 use of SPF 30 cream every morning. Medical evaluation by grade at 3 days, 2, 4 and 8 weeks of use. N=52 patients.

*Measurement and clinical evaluation of inflammatory lesions. **Patient self-assessment".